|
|
Merit Medical Systems Inc (NASDAQ: MMSI) |
|
Price: $89.6000
$1.03 
1.163%
|
| Day's High:
| $89.69000244140625
| Week Perf:
| -1.17 %
|
| Day's Low: |
$ 87.04 |
30 Day Perf: |
2.18 % |
| Volume (M): |
599,640 |
52 Wk High: |
$ 94.75 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$78.18 |
| Open: |
$87.69 |
52 Wk Low: |
$59.74 |
|
|
| Market Capitalization (Millions $) |
5,377 |
| Shares
Outstanding (Millions) |
60 |
| Employees |
7,500 |
| Revenues (TTM) (Millions $) |
1,542 |
| Net Income (TTM) (Millions $) |
139 |
| Cash Flow (TTM) (Millions $) |
93 |
| Capital Exp. (TTM) (Millions $) |
80 |
Business Description
Merit Medical Systems Inc is a leading manufacturer and marketer of disposable medical devices used in interventional, diagnostic and therapeutic procedures. The company was founded in 1987 by Fred P. Lampropoulos, who is the current CEO and Chairman of the Board of Directors.
Merit Medical Systems operates in three main business segments: Cardiovascular, Endoscopy and Peripheral Intervention. Its products range from vascular access products, such as catheters and guidewires, to embolization devices and drainage catheters. The company also provides customized kits and trays for specific procedures.
The headquarters of Merit Medical Systems is located in Salt Lake City, Utah, USA, but it has more than 5,000 employees worldwide and operations in more than 60 countries. The company has a strong global presence, with distribution centers in Europe, Asia, Latin America and the Middle East.
Merit Medical Systems is known for its commitment to innovation and its focus on customer satisfaction. It invests heavily in research and development to develop new products and improve existing ones. The company has also acquired several other medical device companies over the years to expand its product portfolio and global reach.
Merit Medical Systems has received numerous awards and recognitions for its products and services. It has been named among the best places to work in Utah and has been recognized for its commitment to sustainability and social responsibility.
In conclusion, Merit Medical Systems Inc is a leading medical device company with a global presence in the interventional, diagnostic and therapeutic procedures market. The company has a long history of innovation, customer satisfaction, and commitment to sustainability and social responsibility.
Company Address: 1600 West Merit Parkway South Jordan 84095 UT
Company Phone Number: 253-1600 Stock Exchange / Ticker: NASDAQ MMSI
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Clinical Study
Published Tue, Mar 25 2025 7:21 PM UTC
Merit Medical Systems Inc, a prominent player in the medical device industry, recently announced the 12-month efficacy results of its WRAPSODY Cell-Impermeable Endoprosthesis (CIE). As the healthcare sector increasingly focuses on innovative solutions for vascular issues, this release presents an opportunity to examine both the clinical implications of the WRAPSODY CIE and i...
|
| Management Changes
Published Mon, Dec 16 2024 9:00 PM UTC
In a pivotal moment for Merit Medical Systems, Inc. the company has announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. This transition comes at a critical juncture as the company contemplates its strategic direction amidst mixed financial performance and a significant regulatory achievement.Despite Wright s departure, Merit Medical has r...
|
| Clinical Study
Published Fri, Dec 20 2024 2:15 PM UTC
: The U.S. Food and Drug Administration (FDA) has granted premarket approval to the WRAPSODY Cell-Impermeable Endoprosthesis, a novel medical device developed by Merit Medical Systems, Inc. This regulatory milestone is expected to allow the commercialization of the device within the United States beginning in 2025, marking a significant advancement in healthcare technology.T...
|
| Clinical Study
Published Mon, Nov 25 2024 2:15 PM UTC
Arteriovenous grafts (AVGs) are crucial for hemodialysis in patients with end-stage renal disease. These patients are, however, challenged by high failure rates due to stenosis and thrombosis. Current methodologies to maintain patency of these grafts have limited effectiveness, necessitating frequent interventions. This article examines the findings from the WRAPSODY WAVE t...
|
| Merger and Acquisition
Published Fri, Nov 1 2024 1:15 PM UTC
Breaking News: Merit Medical Systems Completes Strategic Acquisition of Cook Medical Lead Management PortfolioSOUTH JORDAN, Utah, Nov. 01, 2024 — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading player in the healthcare technology sector, announced today the completion of its acquisition of Cook Medical s lead management portfolio. This significant transaction, valued...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
2.31 $ |
| Revenues (TTM) |
25.7 $
|
| Cash Flow (TTM) |
1.54 $ |
| Cash |
8.13 $
|
| Book Value |
27.11 $
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
205,606 |
| Net
Income per Employee (TTM) |
18,578 |
| Receivable Turnover Ratio (TTM) |
7.48 |
| Inventory Turnover Ratio (TTM) |
2.37 |
| Asset Turnover Ratio (TTM) |
0.58 |
|
|
| Per Share |
|
| Earnings (TTM) |
2.31 $
|
| Revenues (TTM) |
25.7 $ |
| Cash Flow (TTM) |
1.54 $ |
| Cash |
8.13 $
|
| Book Value |
27.11 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Foundational |
|
 66.91 % |
of total Revenue |
| Therapeutic |
|
33.11 % |
of total Revenue |
| United States |
|
59.33 % |
of total Revenue |
| International |
|
40.69 % |
of total Revenue |
| Single reportable segment |
|
100.02 % |
of total Revenue |
| |
On February 28 2024 the Merit Medical Systems Inc provided following guidance
Merit Medical Systems Inc. reported its financial results for the fourth quarter and year ended December 31, 2023, and provided guidance for fiscal year 2024. The company's constant currency revenue, organic revenue, non-GAAP EPS, non-GAAP net income, non-GAAP operating income and margin, non-GAAP gross profit and margin, and free cash flow were all highlighted as important non-GAAP financial measures.
The company emphasized that these non-GAAP financial measures are important in evaluating its performance and provided a reconciliation of these measures to their most directly comparable GAAP financial measures.
Looking ahead to fiscal year 2024, Merit Medical Systems Inc. expects to see continu...
|
|
|
2.05%